Last news
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

...

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

...

UPDATE – Politecnico di Torino as a Driving Force in Space Research

UPDATE – Politecnico di Torino as a Driving Force in Space Research

...

Unbelievable Jeff! IriusRisk introduces an AI-powered tool which can generate threat models from images

Unbelievable Jeff! IriusRisk introduces an AI-powered tool which can generate threat models from images

...

Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions

Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions

...

EBC Financial Group Expands Partnership with DiNapoli’s Leading Indicators, Revealing Key Strategies for Navigating Black Swan Events

EBC Financial Group Expands Partnership with DiNapoli’s Leading Indicators, Revealing Key Strategies for Navigating Black Swan Events

...

STACK Infrastructure Delivers First Data Center in Japan

STACK Infrastructure Delivers First Data Center in Japan

...

Huber Advanced Materials Announces Price Increase for All Product Lines

Huber Advanced Materials Announces Price Increase for All Product Lines

...

1 ... 217 218 219 220 221 222 223 224 225 ... 863
menu
menu